Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 4/1999

01-04-1999 | Leading Article

Risk of Melanoma with Psoralen/Ultraviolet A Therapy for Psoriasis

Do the Known Risks Now Outweigh the Benefits?

Author: Bernt Lindelöf

Published in: Drug Safety | Issue 4/1999

Login to get access
Metadata
Title
Risk of Melanoma with Psoralen/Ultraviolet A Therapy for Psoriasis
Do the Known Risks Now Outweigh the Benefits?
Author
Bernt Lindelöf
Publication date
01-04-1999
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 4/1999
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199920040-00001

Other articles of this Issue 4/1999

Drug Safety 4/1999 Go to the issue

Review Article

Drugs Hazardous to Healthcare Workers

Review Article

A Risk-Benefit Assessment of HIV Protease Inhibitors

Review Article

A Risk-Benefit Assessment of Oxytocics in Obstetric Practice

Practical Drug Safety

Treating Allergic Rhinitis in Pregnancy

Original Research Article

Lactic Acidosis in Metformin-Treated Patients